153 related articles for article (PubMed ID: 11675354)
1. Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.
Jones DT; Ganeshaguru K; Virchis AE; Folarin NI; Lowdell MW; Mehta AB; Prentice HG; Hoffbrand AV; Wickremasinghe RG
Blood; 2001 Nov; 98(9):2800-7. PubMed ID: 11675354
[TBL] [Abstract][Full Text] [Related]
2. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.
Wieder T; Essmann F; Prokop A; Schmelz K; Schulze-Osthoff K; Beyaert R; Dörken B; Daniel PT
Blood; 2001 Mar; 97(5):1378-87. PubMed ID: 11222383
[TBL] [Abstract][Full Text] [Related]
3. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.
Kimura K; Gelmann EP
J Biol Chem; 2000 Mar; 275(12):8610-7. PubMed ID: 10722700
[TBL] [Abstract][Full Text] [Related]
5. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.
Qin Y; Camoretti-Mercado B; Blokh L; Long CG; Ko FD; Hamann KJ
J Immunol; 2002 Oct; 169(7):3536-44. PubMed ID: 12244143
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
[TBL] [Abstract][Full Text] [Related]
7. Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells.
Droin N; Bichat F; Rébé C; Wotawa A; Sordet O; Hammann A; Bertrand R; Solary E
Blood; 2001 Mar; 97(6):1835-44. PubMed ID: 11238127
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced apoptosis in chronic lymphocytic leukemia.
Stoetzer OJ; Pogrebniak A; Scholz M; Pelka-Fleischer R; Gullis E; Darsow M; Nüssler V; Wilmanns W
Leukemia; 1999 Nov; 13(11):1873-80. PubMed ID: 10557065
[TBL] [Abstract][Full Text] [Related]
9. Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells.
King D; Pringle JH; Hutchinson M; Cohen GM
Leukemia; 1998 Oct; 12(10):1553-60. PubMed ID: 9766499
[TBL] [Abstract][Full Text] [Related]
10. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction.
Byrd JC; Kitada S; Flinn IW; Aron JL; Pearson M; Lucas D; Reed JC
Blood; 2002 Feb; 99(3):1038-43. PubMed ID: 11807010
[TBL] [Abstract][Full Text] [Related]
12. Regulation of TNFRSF6 (Fas) expression in ataxia telangiectasia cells by ionizing radiation.
Albanese J; Dainiak N
Radiat Res; 2000 Dec; 154(6):616-24. PubMed ID: 11096418
[TBL] [Abstract][Full Text] [Related]
13. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction.
Wesselborg S; Engels IH; Rossmann E; Los M; Schulze-Osthoff K
Blood; 1999 May; 93(9):3053-63. PubMed ID: 10216102
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
[TBL] [Abstract][Full Text] [Related]
15. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
Kitada S; Zapata JM; Andreeff M; Reed JC
Br J Haematol; 1999 Sep; 106(4):995-1004. PubMed ID: 10520003
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.
Ferreira CG; Tolis C; Span SW; Peters GJ; van Lopik T; Kummer AJ; Pinedo HM; Giaccone G
Clin Cancer Res; 2000 Jan; 6(1):203-12. PubMed ID: 10656451
[TBL] [Abstract][Full Text] [Related]
17. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.
Qiao L; Studer E; Leach K; McKinstry R; Gupta S; Decker R; Kukreja R; Valerie K; Nagarkatti P; El Deiry W; Molkentin J; Schmidt-Ullrich R; Fisher PB; Grant S; Hylemon PB; Dent P
Mol Biol Cell; 2001 Sep; 12(9):2629-45. PubMed ID: 11553704
[TBL] [Abstract][Full Text] [Related]
18. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
19. Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling.
Perchellet EM; Wang Y; Weber RL; Lou K; Hua DH; Perchellet JP
Anticancer Drugs; 2004 Nov; 15(10):929-46. PubMed ID: 15514562
[TBL] [Abstract][Full Text] [Related]
20. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.
Chu P; Wierda WG; Kipps TJ
Blood; 2000 Jun; 95(12):3853-8. PubMed ID: 10845920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
